Bristol-Myers Squibb Company insider trading

Bought

—

Sold

$2.3M

none on a 10b5-1 plan

Net

−$2.3M

Insiders

3

• Massacesi Cristian

  EVP,Chief Med Offr,Head of Dev

  −$403.5K

  Sep 09, 2026

  6,249 sh · $64.57

• Holzer Phil M

  SVP and Controller

  −$33.8K

  Aug 25, 2026

  500 sh · $67.50

• Elkins David V

  EVP, Chief Financial Officer

  −$1.6M

  Apr 01, 2026

  25,519 sh · $61.60

• Elkins David V

  EVP, Chief Financial Officer

  −$278K

  Apr 01, 2026

  4,481 sh · $62.05

Largest purchase

+$202.2K of BMY by Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) on Apr 25, 2025.

Largest sale

−$2.7M of BMY by Elkins David V (EVP, Chief Financial Officer) on Sep 02, 2025.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

SEC industry classification

Pharmaceutical Preparations

Headquarters

Princeton, NJ

Incorporated in

DE

Listed on

NYSE

SEC Central Index Key

0000014272

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

Open-market purchase (code P)

An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.

Grants and option exercises (codes A, M)

Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.

Cluster buy

Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Are BMY insiders buying or selling?

Between Apr 01, 2026 and Sep 09, 2026, 3 Bristol-Myers Squibb Company insiders made no open-market purchases and 4 sales worth $2.3M, a net sale of $2.3M.

How much BMY stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 6 Bristol-Myers Squibb Company insiders made 4 open-market purchases worth $512.4K and 6 sales worth $4.6M. In the four quarters to Jun 30, 2026: no purchases and 4 sales ($4.5M). The largest purchase was Hirawat Samit buying $202.2K on Apr 25, 2025. The largest sale was Elkins David V selling $2.7M on Sep 02, 2025.

What was the largest recent BMY insider trade?

Elkins David V (EVP, Chief Financial Officer) sold $1.6M of BMY stock on Apr 01, 2026 at about $61.60 a share.

When did an insider last buy BMY shares?

No open-market purchase by a Bristol-Myers Squibb Company insider appears in the filings from Apr 01, 2026 to Sep 09, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Hirawat Samit buying $202.2K on Apr 25, 2025.

Where does BMY insider trading data come from?

From the Form 4 filings Bristol-Myers Squibb Company's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.